GPNX
NOTIFICATION PROCESSED BY IB
12/02/2023
Back to search
Official data from USPTO
EPIZQA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
12/02/2023
Trademark type
Word
Nice classes
5
Filing date
09/07/2022
Registration date
10/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
10/10/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
BARRETT, LEAH
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SAMSUNG BIOEPIS CO., LTD.
Representatives
KAI International IP Law Firm
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hematologicalautoimmuneinflammatoryrespiratorytransplantation-related diseases and disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; antidiabetic preparations; human vaccine preparations; preparations for medical usepreparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for immunoregulation and for treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; dietary supplements
Publications
History of USPTO decisions and trademark events.
13 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/13/2023
FIMP
FINAL DISPOSITION PROCESSED
11/13/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NPUB
NOTICE OF PUBLICATION
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2023
DOCK
ASSIGNED TO EXAMINER
06/22/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/14/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/03/2022
Continuous trademark protection
Get notified about every new filing that threatens EPIZQA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.